Preview Mode Links will not work in preview mode

Apr 22, 2021

Featuring perspectives from Drs Matthew S Davids and Jennifer Woyach on the following topics:

  • Introduction (0:00)
  • Recent advances with BTK inhibitors in the treatment of chronic lymphocytic leukemia (CLL) (1:03)
  • Role of Bcl-2 inhibitor-based regimens in therapy for CLL (42:59)
  • Novel strategies – U2 regimen (umbralisib, ublituximab), CAR T-cell therapy (50:52)

CME information and select publications